|
Name: Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one)
Type: Synthetic opioid
AKA: N/A
![Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) image](https://grammasearch.com/dev/v2/aiimages/brorphine_%281-%281-%281-%284-bromophenyl%29ethyl%29piperidin-4-yl%29-1%2C3-dihydro-2h-benzo%5Bd%5Dimidazol-2-one%29.png)
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
![Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) image](/dev/v2/pages/pubchem_images/134390450.png)
|
|
IV. History
Brorphine, a synthetic opioid, was first synthesized in the 2000s. It is known for its potent analgesic effects and has been used in both medical and illicit contexts. Brorphine's development reflects trends in opioid research, with concerns about its high potency and associated health risks.
|
|
V. Legal Information
Brorphine is a potent opioid with high abuse potential, regulated similarly to other synthetic opioids. In the U.S., it is controlled under the Federal Analog Act, reflecting its similarity to other opioids. Internationally, its status is increasingly regulated to prevent misuse and manage addiction. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Brorphine is a potent opioid analgesic that provides strong pain relief and sedation. It leads to constricted pupils, reduced heart rate, and respiratory depression. Short-term effects include effective pain management, while long-term use may result in addiction and respiratory complications. Overdose risks involve severe respiratory depression. Safe use requires medical oversight. Recent research highlights its potency and the risks associated with opioid use.  |
|
VII. Psychological Effects
Brorphine, a synthetic opioid, targets mu-opioid receptors, leading to significant euphoria and sedation. Immediate effects include mood elevation and analgesia, lasting several hours. Long-term use can lead to severe addiction, cognitive impairments, and mood disturbances. Recent research highlights its potency and risks associated with opioid receptor interactions and psychological dependence.
 |
|
VIII. Culture
Brorphine is a potent synthetic opioid that has emerged in recent years, primarily in the context of the opioid crisis. Its cultural significance lies in its role in illicit drug markets and the associated public health challenges. Media coverage often focuses on the dangers of new synthetic opioids like brorphine and their impact on overdose rates. The substance is used recreationally rather than medicinally, contributing to societal conflicts about drug policy, harm reduction, and the regulation of synthetic opioids. Proponents of harm reduction advocate for safe consumption spaces and increased access to treatment, while opponents emphasize the need for stricter control and enforcement.
 |